BioCentury
ARTICLE | Company News

Novartis sales and marketing update

March 26, 2012 7:00 AM UTC

Novartis launched 75 µg Arcapta Neohaler indacaterol in the U.S. for the maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The wholesale acquisiti...